These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8807874)

  • 1. Hydrolytic antibodies: variations on a theme.
    MacBeath G; Hilvert D
    Chem Biol; 1996 Jun; 3(6):433-45. PubMed ID: 8807874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities of hydrolytic antibodies revealed by their X-ray structures: a review.
    Charbonnier JB; Gigant B; Golinelli-Pimpaneau B; Knossow M
    Biochimie; 1997 Nov; 79(11):653-60. PubMed ID: 9479447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a catalytic antibody with a serine protease active site.
    Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS
    Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct hydroxide attack is a plausible mechanism for amidase antibody 43C9.
    Chong LT; Bandyopadhyay P; Scanlan TS; Kuntz ID; Kollman PA
    J Comput Chem; 2003 Sep; 24(12):1371-7. PubMed ID: 12868101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From molecular diversity to catalysis: lessons from the immune system.
    Schultz PG; Lerner RA
    Science; 1995 Sep; 269(5232):1835-42. PubMed ID: 7569920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.
    Sonkaria S; Boucher G; Flórez-Olvarez J; Said B; Hussain S; Ostler EL; Gul S; Thomas EW; Resmini M; Gallacher G; Brocklehurst K
    Biochem J; 2004 Jul; 381(Pt 1):125-30. PubMed ID: 15053743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
    J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune versus natural selection: antibody aldolases with enzymic rates but broader scope.
    Barbas CF; Heine A; Zhong G; Hoffmann T; Gramatikova S; Björnestedt R; List B; Anderson J; Stura EA; Wilson IA; Lerner RA
    Science; 1997 Dec; 278(5346):2085-92. PubMed ID: 9405338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template.
    Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA
    Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding specificity of hydrolytic catalytic antibody: lessons from the diverse immune system.
    Wada Y; Ono M
    J Protein Chem; 1999 Feb; 18(2):199-204. PubMed ID: 10333294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.
    Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K
    Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse structural solutions to catalysis in a family of antibodies.
    Gigant B; Tsumuraya T; Fujii I; Knossow M
    Structure; 1999 Nov; 7(11):1385-93. PubMed ID: 10574796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.